The adherence of human neutrophils to human umbilical vein endothelial cells (HUVEC) is partially dependent on the CD11/CD18 family of glycoproteins on the neutrophil and ICAM-1 on the HUVEC. The CD18 heterodimer involved in this adherence was evaluated in vitro using subunit-specific monoclonal antibodies (MAbs). The adherence of unstimulated neutrophils to IL-i-stimulated HUVEC was significantly inhibited by anti-CD11a but not CDlb MAbs, while the adherence of fMLP-stimulated neutrophils was significantly inhibited by both anti-CD11a and -CD11b. Anti-CDiia, but not anti-CDlib MAbs, reduced the adherence of unstimulated neutrophils on purified ICAM-1 to the same low level untreated neutrophils exhibited on a control protein, glycophorin. Stimulation with fMLP significantly increased neutrophil attachment to purified ICAM-1, but not to the control protein.
Introduction
Adherence of human neutrophils (PMN) to monolayers of endothelial cells and to protein-coated foreign surfaces is significantly increased by stimulation with chemotactic factors and secretagogues (1) (2) (3) (4) (5) (6) (7) . In each case, the CD lIb/CD 18 (Mac-1) heterodimer on the neutrophil's surface plays a significant role as shown by the markedly inhibitory effect ofseveral monoclonal antibodies reactive with either CDI lb or CD18 (4, 5, 8, 9) . Stimulation of endothelial cells with bacterial endotoxin (LPS) (4, 10, 11) , interleukin 1 (IL-1) (4, 12, 13) , tumor necrosis factor-a (4, 5, (12) (13) (14) , or lymphotoxin (13) increases the adherence of unstimulated PMN. In contrast to the rapid response following chemotactic stimulation ofPMN, this increase is not demonstrable until -1 h after stimulation, and protein synthesis is required. In addition, it appears to be only partially dependent on the CDiI/CD 1 8 family (7) . The specific CDiI/CD 1 8 heterodimer of greatest importance to this cytokine-induced adherence has not been defined. We have recently obtained evidence that the CDl 8-dependent adherence of human PMN to cytokine-stimulated endothelial cells involves intercellular adherence molecule-I (ICAM-1)' on the endothelial surface (7) . In light of recent evidence that ICAM-l (15, 16 ) is a ligand for the CD1 la/CD18 (LFA- 1) heterodimer ( 17, 18) , consideration was given to the possibility that LFA-l plays an important role in the adherence of unstimulated PMN to cytokine-stimulated endothelial cells.
Though LFA-1 seems to be uninvolved in homotypic aggregation of PMN and the adherence of PMN to foreign surfaces (8) , its role in the adherence of PMN to endothelial cells has not been evaluated.
In this study, we provide evidence that LFA-1 is important to the adherence of unstimulated human PMN to human umbilical vein endothelial cells (HUVEC) , that LFA-l is most likely interacting with ICAM-l on the endothelial cell surface, and that LFA-1 is involved in the transendothelial migration induced by activation of HUVEC with cytokines. We also provide evidence that Mac-I is important in the adhesion of chemotactically stimulated PMN to HUVEC, that Mac-I on chemotactically stimulated cells may interact with ICAM-1, and that Mac-I is involved in transendothelial migration.
Metliods
Isolation of polymorphonuclear leukocytes. PMN obtained from healthy adult individuals and two patients with a severe form ofCD18 deficiency (19) were purified from citrate anticoagulated, dextran-sedimented venous blood samples over Ficoll-Hypaque gradients and were suspended in Dulbecco's PBS (Gibco Laboratories, Grand Island, NY), pH 7.4, containing 0.2% dextrose as described (20) . PMN were maintained at 4°C in PBS for up to 4 h at a concentration of 107/ml.
The response of isolated PMN to chemotactic stimulation was assessed using a modification of the shape change assay described previously (6) . Cells were suspended at 106/ml in PBS and incubated at 37°C for 5 min in the following concentrations offMLP (Sigma Chemical Co., St. Louis, MO), 0.1, 0.3, 1.0, 3.0, 10.0 nM; then cells were fixed by addition of an equal volume of 2% glutaraldehyde. Cells were scored morphologically as round, ruffled, or bipolar. The (29, 30) and characterized as to acLDL binding (31) and Factor VIII expression (29) according to established techniques. Cells from 5-10 umbilical cords were pooled and plated in RPMI 1640 containing 10% FCS, antibiotics, heparin (0.1 mg/ml), and endothelial cell growth factor (0.05 mg/ml), and maintained for 3-4 d at 37°C, 5% CO2 humidified atmosphere. Visually confluent monolayers on gelatin (0.1%) and fibronectin (5 4g/cm2)-coated 25-mm round glass coverslips were prepared from first passage cells harvested with 0.05% trypsin and 0.02% EDTA in PBS. Monolayers in fibronectin (5 Mg/cm2) coated 96-well microtiter plates were prepared from first and second passage cells and grown to confluence (1-3 d). HUVEC were pretreated with various concentrations of LPS (Sigma, Escherichia coli 026:B6), or IL-l (Genzyme, cell derived) in most instances for 4 h, a time previously shown to be optimal for the enhancement of neutrophil adherence (7) .
Adherence assay. A visual adherence assay was utilized as previously described (6) with the exception that adherence to HUVEC monolayers was assessed instead of adherence to protein-coated glass. HUVEC monolayers on 25-mm round glass coverslips were washed by dipping three times in two changes of PBS and immediately inserted into the adherence chambers specifically made for use with an inverted microscope and phase-contrast optics. The chambers consisted of two metal plates designed to hold two 25-mm round cover glasses separated by a Sykes-Moore chamber 0-ring (Bellco Glass, Inc., Vineland, NJ). Within this closed compartment PMN could be observed as they contacted the HUVEC monolayer. PMN suspended in PBS (106 cells/ ml) or pretreated with low concentrations of fMLP (2, 3, 6, 32-34) were injected into the chamber and allowed to settle onto the monolayer for a period of 500 s. The number of PMN in contact with the monolayer was determined by counting at least 10 microscopic fields (5OX objective), and the chamber inverted for an additional 500 s. The percentage of cells remaining in contact with the monolayer was determined and is expressed in Results as percent adherence. In blocking experiments, HUVEC were pretreated with MAbs for 20 min then washed three times by dipping in two changes ofPBS before evaluating adherence. PMN were pretreated for 5 min; then the cell suspension was injected into the adherence chamber in most instances without washing. It should be noted that the procedure used in this study does not utilize shear stress (35, 36) as with techniques requiring a washing step (4, 5, 9, (37) (38) (39) . Adherence of PMN to protein-coated glass was performed as previously described (6) with the exception that the glass coverslip was incubated with a 5% solution of human serum albumin (HSA) in PBS for 45 min at 370C, then rinsed in PBS before being inserted into the adherence chamber. PMN were exposed to fMLP (10 nM, 5 min) before injection into the adherence chamber.
The percentage of cells migrating through the endothelial monolayer was also determined using previously described criteria (7, 28, 40, 41) . Under phase contrast optics, PMN adherent to endothelium are round and appear refractile with a surrounding halo. In contrast, the leukocytes become remarkably flattened after migrating to a position between the monolayer and the substratum, they lose the refractile appearance, and intracellular granules are readily seen. The focal plane for these leukocytes is beneath the nuclei of the endothelial cells and that for the PMN adherent to the upper surface of the monolayer is unequivocally above. Preparation ofmonolayers ofpurified ICAM-J. ICAM-l was purified from detergent lysates of SK-Hep-2 cells by immunoaffinity chromatography essentially as previously described (17) with the exception that anti-ICAM-l MAb R6.5.D6 was used in place of MAb RRI/1. In addition, the pH 11.0 buffer wash was omitted. Artificial lipid vesicles containing ICAM-I or control protein glycophorin (Sigma Chemical Co.) were prepared as previously described (17) . Glass coverslips (previously washed in 7X detergent, rinsed in distilled water, treated with 0.5 N NaOH for 4 h, and rinsed in distilled water) were prepared by placing 20 M1 of vesicle suspension in the center of a 25-mm round coverslip and incubating at 37°C for 45 min. In addition, ICAM-I was also prepared by eluting from the R6.5.D6 column in the detergent octylglucoside and diluted to 0.25%, a point below the critical micelle concentration of the detergent. Coverslips were prepared with this material by spotting a 20-Ml aliquot of the ICAM-I solution and then incubating for 45 min at 37°C, followed by incubation ofthe coverslip in 5% HSA for 45 min at 37°C. The coverslips spotted with lipid vesicles containing ICAM-1 or directly coated with ICAM-1 were washed in PBS, mounted in adherence chambers, and adherence of PMN was performed as described above. The presence of ICAM-I on the coverslip was confirmed using immunofluorescence. Coverslips were incubated for 30 min with R6.5.D6 (10 ,ug/ml), washed in PBS, and then incubated with FITC-labeled goat anti-mouse IgG antiserum. Coverslips were then washed in PBS, mounted in glycerol containing phenylene diamine (1 mg/ml), and photographed under epi-illumination (Leitz Diaplan microscope; E. Leitz, Inc., Rockleigh, NJ In addition, each of the anti-Mac-I MAbs at 5 jg/ml inhibited the fMLP-enhanced adherence to HSA-coated glass by greater than 83% (n = 4, P < 0.001) while R3. 1 and TS1/22 at 5 ttg/ml produced no significant effect (n = 6).
To evaluate the possible interaction of the CD18 heterodimers with ICAM-I on the end6thelial cells, the endothelial monolayers were stimulated for 18 h with IL-I (0.3 U/ml). At this time ICAM-1 expression remains high (12) and the ICAM-i-independent adhesion mechanisms perhaps mediated by molecules such as ELAM-I have returned to levels in unstimulated cells (12, 44) . As shown in Fig. 4 (Fig. 6 ). As can be seen, the limit of the spot of ICAM-I was sharply demarcated. R6.5.D6 failed to bind to the coverglass surface following incubation with glycophorin containing vesicle preparations. PMN adhered very poorly to glycophorin vesicles or glycophorin adsorbed to the glass surface, and the few attached cells appeared spherical. In contrast, greater than 65% ofthe PMN adhered to membranes containing ICAM-1 (Fig. 6 ) or to ICAM-l adsorbed to a glass surface, and these cells were ruffled and occasionally bipolar in appearance (Fig. 7) . This was in distinction to the markedly flattened appearance of PMN on untreated glass (Fig. 7) . ! The anti-CDl la, anti-CDl lb, and anti-ICAM-l monoclonal antibodies were evaluated for the ability to inhibit attachment of PMN to ICAM-I ( Fig. 6 and 8) . None of the antiCDl lb antibodies were inhibitory in this setting. Anti-CDl la antibodies produced significant inhibition at concentrations sufficient to saturate binding sites on the PMN (4 gg/ml for R3.1; and 5 jig/ml for TS1/22). R6.5.D6 (10 ;g/ml IgG F(ab')2) inhibited adherence to the same degree as R3. 1, and the combination of the two in the same experiment produced no further inhibition. W6/32 (20 ,g/ml IgG F(ab')2), a nonbinding control, was without effect. Neither R6.5.P6 (Fig. 4) nor W6/32 inhibited the adherence ofPMN to untreated glass.
Chemotactic stimulation of PMN resulted in enhanced adherence to endothelial monolayers stimulated for 18 h with IL-1. To evaluate the possibility that this was augmented adherence to ICAM-1, the effects of fMLP stimulation on adherence of PMN to purified ICAM-I or glycophorin was assessed.
Chemotactic stimulation (fMLP, 10 nM) did not increase adherence to glycophorin (unstimulated, 7±4 PMN/5 fields; MLP, 8+5 PMN/ 5 fields, n = 6) As seen in Fig. 9 A 20-iMl spot of ICAM-l containing lipid vesicle preparation was incubated on a 25 mm diam glass coverslip for 45 min at 370C, washed in PBS, and exposed to R6.5.D6 (10 g/ml IgG) for 30 min. After washing, the coverglass was incubated with 1:100 dilution of FITC-labeled goat antimouse antiserum for 30 min, washed, and photographed. The limit of the spot produced by the ICAM-l-containing vesicle preparation is clearly shown. (B) Phase-contrast microscopic image of adherent PMN at the edge of an ICAM-l -containing vesicle spot. The coverglass with the ICAM-l was inserted into an adherence chamber. PMN suspended in PBS were injected, and allowed to contact the surface for 500 s before the chamber was inverted. After an additional 500 s the attached cells were photographed. In the lower half of the photograph, the PMN are on untreated glass, and in the upper half they are on the membrane. (C) Phase-contrast microscopic image of adherent PMN at the edge of the ICAM-l spot incubated with R6.5.D6 (10 tg/ml F(ab')21. In the lower half of the photograph, the PMN are on untreated glass, and in the upper half, on the membrane. tic stimulation resulted in significant enhancement of attachment to ICAM-1. In contrast to the adherence ofunstimulated PMN to purified ICAM-1, monoclonal antibodies reactive with CDl lb (LM2/1 and OKM10) produced significant inhibition, bringing the level of attachment down to prestimulation levels. R3. 1 also reduced attachment, and the combination of R3.1 with either LM2/1 or OKM10 produced what appeared to be additive effects. This combination produced the same degree of inhibition as did monoclonal antibodies reactive with CD18 (TSl/18) and ICAM-I (R6.5.D6) individually. Note that an isotype-matched binding control, 4A5, did not inhibit adherence either alone or in combination with either LM2/1 or R3.1 (Fig. 9 ).
Effects ofJMLP stimulation on CD18-independent adhesion to endothelium. To determine if chemotactic stimulation activates adherence mechanisms other than those associated with the CD1 1/CD 18 family of glycoproteins, we evaluated the effects of fMLP stimulation on the adherence of CDI8-deficient PMN. Exposure of CD1 8-deficient PMN to fMLP (10 nM) for 5 min did not increase adherence to unstimulated endothelial monolayers (adherence without fMLP, 5.4±1.2%; with tMLP, 3.4±0.7%, n = 4). Adherence was not increased to 18 h IL-I stimulated endothelial monolayers (without MULP, 10.4%; with fMLP, 8.9%, n = 2), or to purified ICAM-1 adsorbed to glass (without fMLP, 2.8±2.0%; with fMLP, 2.5±2.4%, n = 4). Stimulation of HUVEC monolayers with IL-l for 4 h significantly increases attachment of CD18-deficient PMN (7) . As with the other experiments, chemotactic stimulation failed to augment the neutrophil's attachment to HUVEC stimulated for 4 h with IL-1. Figure 9 . Effects of chemotactic stimulation on the adherence of PMN to purified ICAM-l. Coverglasses spotted with vesicles containing ICAM-I were inserted into adherence chambers. The fluid in the adherence chamber was exchanged with PBS, or (a) PBS containing R6.5.D6 (10 g/ml F(ab')2). After 15 min incubation at room temperature the chamber fluid was exchanged with PMN suspended in PBS alone (open bars) or PBS containing 10 nM fMLP (hatched bars) with or without monoclonal antibodies (5 ug/ml IgG) as indicated. Adherence was determined using a visual assay at room temperature. ( ), number of separate experiments; *P < 0.01 when compared to PBS alone; **P < 0.01 when compared to fMLP without monoclonal antibodies; ***P < 0.01 when compared to values when PMN were exposed to both fMLP and R3. 1.
CDJla and CDllb in the transendothelial migration of human neutrophils. Migration of unstimulated PMN through monolayers ofunstimulated HUVEC on gelatin-coated glass is rarely seen during the 1,000-s observation period used in these studies (7) . However, when the HUVEC monolayer has been exposed to IL-l (0.3 U/ml) for 3-4 h before the application of unstimulated PMN, > 70% of the PMN become activated upon contact with the monolayer as evidenced by their ruffled and bipolar morphology (7). These cells migrate through the endothelium to a position between the monolayer and the substratum, and appear flattened under phase-contrast microscopy, though they still retain the motile, bipolar configuration. We have previously shown that anti-CD 18 and anti-ICAM-1 monoclonal antibodies markedly inhibit this migration, and that CD1 8-deficient PMN fail to migrate (7) . To extend this work, we utilized the anti-CD 1 la and anti-CD 1 lb monoclonal antibodies (Fig. 10) . The three anti-CD 1 lb MAbs and the binding control MAb, 4A5, failed to significantly inhibit migration. In contrast, both anti-CD 1 la MAbs markedly inhibited migration. Of particular interest was the finding that when used in combination with R3. 1, anti-CD 1 lb MAbs 904, OKM10, and LM2/1 profoundly reduced migration to levels significantly less than with R3. 1 Figure 10 . Transendothelial migration of human PMN and effects of monoclonal antibodies. HUVEC monolayers on gelatin-coated glass were incubated with IL-I (0.5 U/ml) for 4 h, washed by dipping in PBS and inserted into adherence chambers. PMN were incubated for 15 min at room temperature in either PBS or PBS containing the indicated monoclonal antibody (5 gg/ml IgG). This cell suspension was injected into the adherence chamber, and transendothelial migration was determined after incubation at 37°C for 1,000 s using a visual assay. ( ), number of separate experiments; *P < 0.01 when compared with the PBS control; **P < 0.01 when compared with the level of adherence in the presence of R3. (12, 44) while ICAM-1 expression remains high (7, 12) , and the anti-ICAM-l MAb, R6.5.D6, produces > 85% inhibition of adherence. LFA-1 is implicated since CD18-deficient PMN adhere very poorly to these monolayers, and the anti-CD 1 la MAb, R3. 1, produces 83.4% inhibition of adherence while an anti-CD 1 lb MAb (LM2/1) is without effect. (b) Unstimulated PMN adhere to HUVEC monolayers stimulated for 3-4 h with IL-1 or LPS in significantly greater numbers than to unstimulated monolayers. ICAM-1 is implicated in this adherence since ICAM-l expression is high at this time (7, 12) , and the anti-ICAM-1 MAb produces significant inhibition of adherence (7) . LFA-1 is implicated since the adherence ofCD18-deficient PMN is significantly less than that of normal PMN, the anti- CDl8 (TSl/ 18) or ICAM-I (R6.5.D6) significantly reduce this low level of adherence (7) . In contrast to ELAM-1, there is a low level of constitutive expression of ICAM-1 on endothelial cells in vitro ( 12, 44) .
Assuming that the inhibitory effect of the specific MAbs discussed above is the result of steric hindrance of receptor-ligand interactions, the overall weight of this evidence indicates that the unstimulated neutrophil uses a molecular mechanism for adhesion in common with lymphocytes, the receptor-ligand interaction of LFA-l and ICAM-1 (17, 18, (45) (46) (47) . The possibility that anti-LFA-I antibodies are signaling in the neutrophil downregulation of as yet unidentified adhesive mechanisms seems unlikely in light of the results with CDl 8-deficient cells. The possibility that the anti-ICAM-1 MAb is signaling a reduction in other adherence mechanisms is discounted by the results using highly purified ICAM-1 in artificial membranes (17 (12, 44) . As in the experiments with purified ICAM-1, Mac-l appears to play an important role in both experimental settings with HUVEC monolayers. In earlier studies an anti-CD 1 lb MAb, 60.1 (4, 9), and an anti-ICAM-l MAb, R56.5.D6 (7) markedly inhibited adherence of stimulated PMN to unstimulated HUVEC. In the current study we show that on 18-h IL-1 stimulated HUVEC, anti-CD 1 lb MAbs are inhibitory, and in combination with an anti-CD 1 la MAb (R3. 1), reduce adherence to the same low level induced by the anti-ICAM-l MAb, R6.5.D6 (7) . Thus, the current evidence indicates that Mac-1 (CD1 lb/CD 18) is recruited by chemotactic stimulation to interact with ICAM-1 on the surface of the endothelial cell since CDl lb-dependent adhesion to HUVEC is blocked by the anti-ICAM-1 MAb. That Mac-1 may recognize ligands other than iC3b is supported by recent investigations from several laboratories (8, (54) (55) (56) (57) (58) .
Within the first few minutes of contacting IL-1 stimulated endothelial monolayers, previously unstimulated normal PMN ruffle, assume a bipolar configuration, and migrate through the monolayer (7, 59 ). CD18-deficient PMN ruffle and become bipolar in shape, but fail to migrate through the monolayer (7). While CD 1 8 and ICAM-1 are necessary for this migration (7), the specific heterodimers of the CDl 1/CD 1 8 family have not been previously defined. The results in this report indicate that both Mac-l and LFA-1 are involved, since MAbs reactive with LFA-1 produce partial inhibition, and combinations of anti-CD 1 la and anti-CD 1 lb MAbs are as inhibitory as the anti-CD 1 8 MAb, TS 1/18.
The failure of anti-CD 1 lb MAbs to inhibit transendotheHal migration when used alone is intriguing. The ruffling and shape change of the PMN upon encountering the stimulated endothelium are consistent with cells exposed to a chemotactic factor (6, 60) , an interpretation supported by the finding of chemotactic activity in conditioned media from cultures of endothelial cells (61) (62) (63) . That chemotactic stimulation recruits the involvement of Mac-l in adherence to endothelial cells may account for the observation that anti-CD 1 lb MAbs potentiate the inhibition of transendothelial migration caused by anti-CD 11 a MAbs. If the interaction of LFA-1 with ICAM-1 is sufficient for transendothelial migration to occur, then blocking Mac-1 would have little effect. However, when LFA-1 is blocked by anti-CD1 la MAbs, adhesion and migration may be promoted by Mac-1 as a result of local chemotactic stimulation, thus accounting for the additive effects of the anti-CD 1 lb MAbs. The following considerations may be important as well: Mac-1 appears to be necessary for migration of PMN over a surface (8) , though its role can be minor when PMN are migrating through a three-dimensional matrix (64) . If adhesion-independent mechanisms are predominantly used by PMN for transendothelial migration following attachment to cytokine-stimulated, confluent monolayers of HUVEC, the ability of anti-CD 1 1/CD 1 8 and anti-ICAM-1 MAbs to inhibit migration would be limited to their ability to block the attachment of PMN to the monolayer. It is important to note that these MAbs, as shown in this and previous reports (8), do not inhibit at the level of chemotactic activation of bipolar shape change, a necessary step in the locomotion of PMN (60); and that the anti-CD 1 Ia MAbs neither inhibit nor promote Mac-1-dependent functions such as adhesion to proteincoated glass and homotypic aggregation (8) .
The factors that account for attachment and emigration of PMN through endothelium appear to be complex. It is now clear that cytokine-stimulated endothelial cells play an active role through increased expression of ELAM-1, ICAM-1 and probably additional adhesive factors. They also appear to produce a chemotactic stimulus that could modulate the adhesive molecules on the neutrophil by recruiting the involvement of Mac-I in the cell's attachment to ICAM-1.
